Alleima AB – Nomination Committee’s proposal for Board of Directors for the 2026 Annual General Meeting

Alleima AB's Nomination Committee proposes re-election of board members Göran Björkman, Claes Boustedt, Ulf Larsson, Andreas Nordbrandt, Susanne Pahlén Åklundh, Victoria Van Camp and Karl Åberg, with Andreas Nordbrandt proposed to be re-elected as Chair; the Annual General Meeting is scheduled for April 29, 2026 and further proposals will be published in the meeting notice. The committee is chaired by Fredrik Lundberg and includes representatives from AB Industrivärden, Lundbergföretagen AB, Swedbank Robur Funds and AFA Försäkring; Alleima reported approximately 6,800 employees and about SEK 19 billion in revenue across ~80 countries in 2025 and is listed on Nasdaq Stockholm under the ticker ALLEI.

Analysis

Market structure: The nomination committee’s re‑election slate signals governance continuity at Alleima (ALLEI) and is a neutral short‑term catalyst — winners are incumbent shareholders (AB Industrivärden) and management continuity; losers are activists seeking board change. Competitive dynamics are largely unchanged: Alleima’s high‑value alloys business retains premium pricing power versus commodity stainless peers, so market‑share shifts are more likely at the margin (niche aftermarket and hydrogen/fuel‑cell coated strip). Supply/demand fundamentals remain driven by end markets (energy, aerospace, hydrogen); this governance news does not alter raw‑material exposure (nickel, chromium, scrap) so commodity and FX cross‑asset channels remain the primary drivers, not board composition.

Risk assessment: Tail risks include operational failure at a key mill, a major customer contract loss, or regulatory/ESG remediation costs — each could cut EBITDA by >20% and materialize within 6–18 months. Immediate (days) impact should be muted around the AGM notice; short term (weeks–months) risks center on investor reaction pre‑AGM (Apr 29, 2026) and commodity swings; long term (quarters–years) the main dependency is capital allocation by dominant shareholders (Industrivärden) and execution of R&D roadmap. Catalysts to watch: Q1 results, commodity moves ±10% (nickel/chrome), AGM votes, and any investor presentations outlining capital deployment.

Trade implications: Direct play: small tactical long in ALLEI ahead of Q2 order visibility if price offers a ≥3% pullback vs 5‑day VWAP; expected holding 3–12 months. Pair trade: long ALLEI vs short commodity stainless like OUT1V.HE or SSAB‑A.ST (6–12 month horizon) to capture specialty‑premium resilience; size relative positions 1–2% each. Options: if ALLEI implied vol > realized vol by 25–30%, sell 30–60 day straddles sized to 0.5–1.0% notional; otherwise buy 3–6 month puts (10% OTM) as tail hedges.

Contrarian angles: Markets will treat this as neutral, but continuity can be undervalued — if Alleima executes (>200 bps margin expansion vs peers) re‑rating of 6–12% is plausible over 12 months. Conversely, entrenchment can block needed M&A/cost moves; if management underdelivers, downside could exceed 15% relative to peers. Historical parallels: stable boards in engineering niche names often precede multi‑year outperformance when R&D converts to commercial wins (Sandvik/Sandvik Materials era), so monitor execution metrics (order book, margin conversion) closely.

Key Decisions for Investors

• Establish a 2% long position in Alleima (ALLEI) on any intra‑day pullback ≥3% from the 5‑day VWAP ahead of the AGM; hold through April 29, 2026 and reassess on Q1 earnings — target 12‑month upside 8–12%, stop‑loss −12%.
• Implement a 1.5% pair trade: long ALLEI vs short Outokumpu (OUT1V.HE) or SSAB A (SSAB‑A.ST) sized equally, 6–12 month horizon; exit if Alleima’s trailing 12‑month EBITDA margin advantage falls below 150 bps vs the peer median.
• If ALLEI implied volatility trades >25% above realized vol, sell 30–60 day straddles (size 0.5–1.0% notional) to harvest low expected post‑AGM movement; if macro risk rises (PMI drop ≥2% m/m) switch to buying 3–6 month 10% OTM puts (0.5–1.0% notional) as insurance.
• Reduce commodity stainless cyclicals exposure by 2–4% (e.g., OUT1V.HE, SSAB‑A.ST) if global industrial orders or PMI fall >2% m/m; redeploy proceeds into specialty alloy exposure (ALLEI) or cash to preserve downside capital.